Molina Healthcare (MOH) Research & Development (2010 - 2018)

Molina Healthcare has disclosed Research & Development across 9 years of filings, most recently posting $120.0 million for Q1 2018.

• Research & Development for Q1 2018 came in at $120.0 million, down 1.64% year-over-year; the trailing twelve-month figure through Mar 2018 was $490.0 million (up 2.08% YoY), and the FY2017 annual result was $492.0 million, up 1.44% from the prior year.
• Research & Development came in at $120.0 million for Q1 2018 at Molina Healthcare, down from $123.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $127.0 million in Q1 2016 to a low of $33.0 million in Q2 2015.
• The 5-year median for Research & Development is $116.0 million (2016), against an average of $85.1 million.
• Across the five-year window, Research & Development decreased 15.14% in 2015 and surged 252.78% in 2016, its largest moves.
• Molina Healthcare's Research & Development stood at $39.2 million in 2014, then surged by 129.77% to $90.0 million in 2015, then jumped by 36.67% to $123.0 million in 2016, then changed by 0.0% to $123.0 million in 2017, then decreased by 2.44% to $120.0 million in 2018.
• The last three Research & Development figures came in at $120.0 million (Q1 2018), $123.0 million (Q4 2017), and $123.0 million (Q3 2017), per Business Quant data.